Factors associated with weight gain in women after diagnosis of breast cancer

Journal of the American Dietetic Association

Volumn 99, Issue 10, 1999, Pages 1212-1218

  Rock, Cheryl L ^a,b   Flatt, Shirley W ^b   Newman, Vicky ^a   Caan, Bette J ^c   Haan, Mary N ^d   Stefanick, Marcia L ^e   Faerber, Susan ^b   Pierce, John P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CALORIC INTAKE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUTRITION; PHYSICAL ACTIVITY; POSTMENOPAUSE; RECURRENCE RISK; RISK FACTOR; WEIGHT GAIN;

EID: 0032882357     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(99)00298-9     Document Type: Article

References (43)

1. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97:519-526.
2. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997;216:28-43.
3. Senie RT, Rosen PP, Phodes P, Lesser ML, Kinne DW. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med. 1992;116:26-32.
4. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SC, Buzdar AU. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med. 1993;119:18-25.
5. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. Cancer. 1995;76:275-283.
6. Monnin S, Schiller MR, Sachs L, Smith AM. Nutritional concerns of women with breast cancer. J Cancer Educ. 1993;8:63-69.
7. Hoskin PJ, Ashley S, Yarnold JR. Weight gain after primary surgery for breast cancer - effect of tamoxifen. Breast Cancer Res Treat. 1992;22:129-132.
8. Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Maillard JA, Tschetter LK, Long HF, Gerstner JG, Windschitl HE. Combination hormonal therapy with tamoxifen plus fluoxymestrone versus tamoxifen alone in post-menopausal women with metastatic breast cancer. Cancer. 1991;67:886-891.
9. Fisher B, Costantino J, Redmond C. A randomized trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989;320:479-484.
10. Grey AB, Stapleton JP, Evans MC, Reid IR. The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal post-menopausal women. J Clin Endocrinol Metab. 1995;80:3191-3195.
11. Rock CL, Flatt SW, Wright FA, Faerber S, Newman V, Kealey S, Pierce JP. Responsiveness of carotenoids to a high vegetable diet intervention designed to prevent breast cancer recurrence. Cancer Epidemiol Biomarkers Prev. 1997;6:617-623.
12. Pierce JP, Faerber S, Wright FA, Newman V, Flatt SW, Kealey S, Rock CL, Hryniuk W, Greenberg ER. Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr Cancer. 1997;28: 282-288.
13. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clin Trials. 1998;19:61-109.
14. Simko MD, Cowell C, Gilbride JA. Nutrition Assessment. Gaithersburg, Md: Aspen Publishers; 1995.
15. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF, Paffenbarger RS. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71-80.
16. Goodwin PJ, Panzarella T, Boyd NF. Weight gain in women with localized breast cancer - a descriptive study. Breast Cancer Res Treat. 1988;11:59-66.
17. Staging for carcinoma of the breast. In: Beahrs O, Henson D, Hutter R, Myers M, eds. Manual for Staging of Cancer. 3rd ed. Phladelphia, Pa: JB Lippincott; 1988.
18. Najjar MF, Rowland M. Anthropometric Reference Data and Prevalence of Overweight, United States, 1976-80. Hyattsville, Md: National Center for Health Statistics: 1987. Advance data from Vital and Health Statistics, No. 238.
19. The Surgeon General's Report on Nutrition and Health. Washington, DC: US Dept of Health and Human Services; 1988. DHHS (PHS) publication 88-50210.
20. Foltz AT. Weight gain among stage II breast cancer patients: a study of five factors. Oncol Nurs Forum. 1985;31-36.
21. Grindel CG, Cahill CA, Walker M. Food intake of women with breast cancer during their first six months of chemotherapy. Oncol Nurs Forum. 1989;16:401-407.
22. Demark-Wahnefried W, Hars V, Conaway M, Havlin K, Rimer B, McElveen G, Winer EP. Reduced rates of metabolism and decreased activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr. 1997;65: 1495-1501.
23. Trantham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER, Willett WC. Body size and risk of breast cancer. Am J Epidemiol. 1997;145:1011-1019.
24. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278:1407-1411.
25. Ziegler RG, Hoover RN, Nomura AM, West DW, Wu AH, Pike MC, Lake AJ, Horne-Ross PL, Kolonel LN, Siiteri PK, Fraumeni JF. Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Watt Cancer Inst. 1996;88:650-660.
26. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat. 1990;16:205-214.
27. Camoriano JK, Loprinzi CL, Ingle JN, Therneau T, Krook J, Veeder M. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990;8:1327-1334.
28. Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman L. Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat. 1986;7:23-29.
29. Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd N. Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 1985;5:195-200.
30. Huntington MO. Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer. 1985;56:472-474.
31. Knobf MK, Mullen JC, Xistris D, Moritz PA. Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 1983; 10:28-34.
32. Williamson DF, Kahn HS, Byers T. The 10-y incidence of obesity and major weight gain in black and white US women aged 30-55 y. Am J Clin Nutr. 1991;53(suppl):151S-158S.
33. Sobal J, Stunkard AJ. Socioeconomic status and obesity: a review of the literature. Psychol Bull. 1989;105:260-275.
34. McDowell MA, Briefel RR, Alaimo K, Bischoff AM, Caughman CR, Carroll MD, Loria CM, Johnson CL. Energy and Macronutrient Intakes of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Hyattsville, Md: National Center for Health Statistics; 1994. Advance data from Vital and Health Statistics, No. 255.
35. Crespo CJ, Keteyian SJ, Heath GW, Sempos CT. Leisure-time physical activity among US adults. Results from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 1996;156:93-98.
36. Williamson DF. Descriptive epidemiology of body weight and weight change in US adults. Ann Intern Med. 1993;119:646-649.
37. Williamson DF, Kahn HS, Remington PL, Anda RF. The 10-year incidence of overweight and major weight gain in US adults. Arch Intern Med. 1990; 150:665-672.
38. Williamson DF, Madans J, Pamuk E, Flegal KM, Kendrick JS, Serdula MK. A prospective study of childbearing and 10-year weight gain in US white women 25-45 years of age. Int J Obes. 1994;18:561-569.
39. Bostrom G, Diderichsen F. Socioeconomic differentials in misclassification of height, weight and body mass index based on questionnaire data. Int J Epidemiol. 1997;26:860-866.
40. Rowland ML. Self-reported weight and height. Am J Clin Nutr. 1990;52: 1125-1133.
41. Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S. The predictive validity of body mass index based on self-reported weight and height. Int J Obes. 1988;13:441-453.
42. Freudenheim JL. A review of study designs and methods of dietary assessment in nutritional epidemiology of chronic disease. J Nutr. 1993;123:401-405.
43. Kristal AR, Andrilla HA, Koepsell TD, Diehr PH, Cheadle A. Dietary assessment instruments are susceptible to intervention-associated response set bias. J Am Diet Assoc. 1998;98:40-43.